Nam W. Kim Ph.D

Chief Executive Officer & Chief Technology Officer

 

Co-Founder
Nam is a seasoned scientist and executive with over 25 years of experience in developing and commercializing novel diagnostics tests at several cutting-edge biotechnology companies including  Geron, and diaDexus where he was responsible for the development of novel diagnostic and prognostic markers for cancer and cardiovascular diseases.

Sholeh Jahanfard

President & Chief Operating Officer

 

Co-Founder

Sholeh is a clinical diagnostic expert with over 35 years of clinical diagnostics and life-science industry including  Kaiser Permanente, LifeScan (a Johnson & Johnson Company), DiaSorin, Incell Dx and Enzo LifeSciences. She has launched several novel tests both in the U.S. and internationally and managed the sales and marketing activities for ENZO LifeScience in Europe. 

Shahram Gholami M.D.

Chief Medical Officer

Shahram is an internationally recognized urologist in the field of minimally invasive laparoscopic and robotic surgery and cystoscopy.  He is a practicing clinician with a renowned urology clinic located in the heart of silicon valley and affiliated with Good Samaritan Hospital and Stanford University.

About Us

At KDx Diagnostics, we believe in the advancement of bladder cancer recognition. Ever since our establishment in 2016, we have worked endlessly to achieve the highest sensitivity and specificity bladder cancer test. With the creation of our URO17™ test, we have not only achieved such an inexpensive and non-invasive test, but also one that is simpler to use for the patient with results that are more accurate than ever before. We hope with the introduction of the URO17™, we can strive for quicker recognition and response to the dangers of cancer and help out patients achieve a peaceful and care-free life.

Consultants and Advisors

Business:

Doug Sweet – Former VP Marketing Agilent, Roche, Syva & Mol Devices
Vladimir Ostioich– Co-founder, Abaxis Inc.
Melya Crameri-Hughes – Ventec Partners

Clinical and Scientific/Collaborators:

Kenneth Shroyer, M.D., Ph.D. - Stony Brook Medicine

Luisa Escobar-Hoyos, M.D., Ph.D. - Stony Brook Medicine

Sima Porten, M.D., MPH – UCSF

Nikhil Vasdev, MBBS, MRCS, ChM, FRCS – Lister Hospital

 

FDA Regulatory:

Mark Sarno – CEO Vision Biotechnology
Erika B. Ammirati - Regulatory Consulting

Copyright © All Rights Reserved

LEGAL NOTICE; By accessing, browsing and/or otherwise using this website, you acknowledge that you have read, understood, and are bound by the KDx Diagnostics Inc. Website Terms and Conditions, and Privacy Policy and shall comply with all applicable laws and regulations. If you do not agree to these terms, do not use this website. Additionally, this website contains information on products that is targeted to many different audiences and may contain product details or information otherwise not accessible or valid in your country. Please be aware that KDx Diagnostics Inc. does not take any responsibility for your decision to access any such information on this website that may not comply with a legal process, regulation, registration or usage in the country of your origin.